90 studies found for:    Open Studies | "Endometrial Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Exercise as an Intervention in Endometrial Cancer Survivors
Conditions: Endometrial Cancer;   Quality of Life
Intervention: Behavioral: Exercise
22 Recruiting Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
Conditions: Cervical Cancer;   Endometrial Cancer
Interventions: Radiation: 18F-Fluorodeoxyglucose (18F-FDG);   Device: PET/CT imaging
23 Recruiting Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Selinexor
24 Recruiting Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
Condition: Endometrial Cancer
Intervention:
25 Recruiting Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.
Conditions: Cervix Cancer;   Endometrium Cancer;   Ovarian Cancer;   Carcinoma in Situ of Fallopian Tube
Intervention: Device: Confocal Laser Endomicroscopy (CLE)
26 Recruiting Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: everolimus and letrozole
27 Recruiting Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
Conditions: Endometrial Cancer;   Obesity
Interventions: Dietary Supplement: Dietary Intervention;   Other: Informational Material;   Other: Dietary Education;   Dietary Supplement: Weight Maintenance;   Other: Average score of Obesity and Weight-Loss Quality of Life Questionnaire
28 Not yet recruiting A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
Condition: Endometrial Cancer
Intervention: Drug: BMN 673
29 Recruiting Lymphedema After Primary Surgery for Endometrial Cancer
Conditions: Carcinoma of the Endometrium;   Hysterectomy;   Lymphadenectomy
Intervention: Procedure: Lymphadenectomy
30 Recruiting Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Condition: Endometrial Cancer
Interventions: Device: ISB dye and standard white light imaging;   Device: ICG dye and FireFly fluorescence imaging
31 Recruiting Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA
Condition: Recurrent or Persistent Endometrial Carcinoma
Intervention: Drug: Sodium cridanimod
32 Not yet recruiting Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Condition: Endometrial Cancer
Intervention: Drug: Metformin
33 Recruiting Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
Conditions: Complex Atypical Hyperplasia;   Endometrial Cancer
Intervention: Drug: Metformin
34 Recruiting Phase II Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies
Conditions: Ovarian Carcinoma;   Endometrial Carcinoma;   Cervical Carcinoma
Interventions: Drug: Selinexor Dose A;   Drug: Selinexor Dose B;   Drug: Selinexor Dose C
35 Recruiting Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma
Condition: Endometrial Carcinoma
Intervention: Dietary Supplement: Curcuphyt
36 Recruiting HuMax®-TF-ADC Safety Study in Patients With Solid Tumors
Conditions: Ovary Cancer;   Cervix Cancer;   Endometrium Cancer;   Bladder Cancer;   Prostate Cancer (CRPC);   Esophagus Cancer;   Lung Cancer(NSCLC)
Intervention: Drug: HuMax-TF-ADC
37 Recruiting A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
Condition: Endometrial Cancer
Intervention: Drug: Fluorescein
38 Recruiting Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer
Conditions: Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Primary Peritoneal Cavity Cancer;   Stage IIIA Endometrial Carcinoma;   Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Endometrial Carcinoma;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Endometrial Carcinoma;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: carboplatin;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: gemcitabine hydrochloride;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
39 Recruiting Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery
Conditions: Stage I Endometrial Carcinoma;   Stage II Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Procedure: lymph node mapping;   Procedure: sentinel lymph node biopsy;   Drug: isosulfan blue;   Drug: indocyanine green solution;   Procedure: therapeutic conventional surgery;   Procedure: lymphadenectomy
40 Recruiting Lymphedema in Endometrial Cancer
Conditions: Lower Extremity Lymphedema;   Endometrial Cancer
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years